Through a detailed comparison of the heterogeneity of HER2 + IBC and nIBC tumour cells, we found that EMT, the interferon response and enrichment scores for invasive features were more strongly activated in IBC tumour cells, a finding that is more in line with previously reported results [60, 61]. This evidence concerns the gene ERBB2 and inflammatory breast carcinoma.